Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.64B P/E - EPS this Y 51.60% Ern Qtrly Grth -
Income -129.53M Forward P/E -11.03 EPS next Y 12.40% 50D Avg Chg -6.00%
Sales 47.17M PEG -0.35 EPS past 5Y - 200D Avg Chg 9.00%
Dividend N/A Price/Book 5.39 EPS next 5Y 69.30% 52W High Chg -30.00%
Recommedations 1.60 Quick Ratio 2.76 Shares Outstanding 51.93M 52W Low Chg 119.00%
Insider Own 14.12% ROA -19.03% Shares Float 27.69M Beta 0.03
Inst Own 100.32% ROE -51.56% Shares Shorted/Prior 3.97M/3.98M Price 34.20
Gross Margin 100.00% Profit Margin -274.59% Avg. Volume 563,691 Target Price 67.17
Oper. Margin -299.94% Earnings Date - Volume 436,561 Change 0.06%
About Arcellx, Inc.

Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 2 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It is also developing ACLX-001, an immunotherapeutic combination composed of ARC-T cells and bi-valent SparX proteins targeting BCMA to treat r/r MM; ACLX-002 and ACLX-003 for treating r/r acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS); and product candidates for solid tumor programs. It has strategic alliance with Kite Pharma, Inc. to co-develop and co-commercialize CART-ddBCMA. The company was formerly known as Encarta Therapeutics, Inc. and changed its name to Arcellx, Inc. in January 2016. Arcellx, Inc. was incorporated in 2014 and is headquartered in Gaithersburg, Maryland.

Arcellx, Inc. News
02/15/24 The 3 Biotech Stocks That Could Make Your February Unforgettable
02/01/24 Arcellx, Inc. (NASDAQ:ACLX) Shares Could Be 40% Below Their Intrinsic Value Estimate
01/16/24 Healthcare Heroes: 3 Biotech Stocks Poised to Cure What Ails the Market
12/22/23 Chief Medical Officer Christopher Heery Sells 120,000 Shares of Arcellx Inc
12/15/23 Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development
12/08/23 Arcellx Announces Continued Robust Long-Term Responses from Its CART-ddBCMA (anito-cel) Phase 1 Expansion Trial in Patients with Relapsed or Refractory Multiple Myeloma at ASH
11/30/23 3 Biotech Stocks That Could Be Multibaggers in the Making
11/21/23 These Stocks Are Exploding In The November Stock Market Rally
11/17/23 The Zacks Analyst Blog Highlights Arcellx, Bristol Myers Squibb, Solid Biosciences, Vertex Pharmaceuticals and CRISPR Therapeutics
11/16/23 Biotech Stock Roundup: BMY's Drug Approval, VRTX & CRSP Gene Therapy Get MHRA Nod
11/16/23 Arcellx (ACLX) Up 5% on Partnership Expansion With Gilead
11/15/23 Arcellx, A Top 2% Stock, Breaks Out After Inking A $285 Million Deal With Gilead
11/15/23 Gilead expands Arcellx cancer cell therapy deal
11/15/23 ARCELLX AND KITE ANNOUNCE EXPANSION IN STRATEGIC PARTNERSHIP
11/15/23 Kite and Arcellx Announce Expansion in Strategic Partnership
11/13/23 Arcellx Inc (ACLX) Reports Q3 2023 Financial Results and Business Updates
11/13/23 Arcellx Provides Third Quarter 2023 Financial Results and Business Highlights
11/12/23 Industry Analysts Just Upgraded Their Arcellx, Inc. (NASDAQ:ACLX) Revenue Forecasts By 11%
11/09/23 There Were 181 IPOs In 2022: $1K In Either Of These Two Would Have You Up 200%+
11/09/23 Is a Surprise Coming for Arcellx (ACLX) This Earnings Season?
ACLX Chatroom

User Image TickerDD_com Posted - 4 days ago

From 2/16/2024, looking back across 22 Month-Ends for ACLX, Percentage Change of Average Monthly Price had More Positives (77%) while Percentage Change of Average Monthly Volume had All Positives (100%) $ACLX #ACLX #ACLXStock #TickerDD #ACLXPrice https://www.youtube.com/watch?v=H7g4XDiLsQI

User Image insiderbuyingselling Posted - 1 week ago

$ACLX new insider selling: 10111 shares. http://insiderbuyingselling.com/?t=ACLX

User Image TalkMarkets Posted - 2 weeks ago

Decoding Bearish Analog And The Warning Signs You Can't Ignore $ACLX $SPX $SRPT https://talkmarkets.com/content/stocks--equities/decoding-bearish-analog-and-the-warning-signs-you-cant-ignore?post=430831&userid=166882

User Image popculture Posted - 2 weeks ago

$ACLX

User Image StockInvest_us Posted - 3 weeks ago

Signal alert: $ACLX - Overbought Trend Short (Overvalued) https://stockinvest.us/l/PO41dTkTtu

User Image VirmoMopire Posted - 01/30/24

$ACLX Looks like it is making some moves today! 📈

User Image szaman Posted - 01/28/24

$ACLX chart via @MarketSmith #IBDpartner. Biotech IPO breaking out again with volume. https://bit.ly/424cWtr

User Image GuerillaStockTrading Posted - 01/28/24

Arcellx $ACLX A Promising Biotech Gem SWEET LOOKING ASCENDING TRIANGLE BREAKOUT, THIS NAUGHTY GIRL COULD RUN https://www.guerillastocktrading.com/arcellx-a-promising-biotech-gem/

User Image Stoop_Kid Posted - 4 weeks ago

$ACLX breakouttt

User Image FlynancialAnalyst Posted - 1 month ago

$ACLX also worth noting the rapid decline in short float % the last few months TrendEdge.app/asset/aclx #ShareStatistics

User Image FlynancialAnalyst Posted - 1 month ago

$ACLX $3.08B mc $XBI leader rotating up off 10 wk SMA on volume today. All systems go Fully institutionally owned, rising rapidly over the last 2 years. Only 202 watchers on Stocktwits #HiddenGem $100+ in time

User Image popculture Posted - 1 month ago

$ACLX Christopher Heery, Chief Medical Officer ,sold 120,000 shares of the company on December 18, 2023 he should’ve held

User Image tickeron Posted - 1 month ago

A good addition to the trading plan for the week! $ACLX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators: https://srnk.us/go/4965279

User Image MarketBeatInsiderTrades Posted - 1 month ago

Arcellx CFO Michelle Gilson Sells $470,568.78 in $ACLX www.marketbeat.com/stocks/NASDAQ/ACLX/insider-trades/

User Image MarketBeatInsiderTrades Posted - 1 month ago

Arcellx Insider Christopher Heery Sells $419,941.46 in $ACLX www.marketbeat.com/stocks/NASDAQ/ACLX/insider-trades/

User Image cctranscripts Posted - 1 month ago

Arcellx, Inc.'s Chief Financial Officer just disposed of 8,514 shares https://www.conferencecalltranscripts.org/summary/?id=12850943 $ACLX

User Image cctranscripts Posted - 1 month ago

Arcellx, Inc.'s Chief Medical Officer just disposed of 7,598 shares https://www.conferencecalltranscripts.org/summary/?id=12850981 $ACLX

User Image risenhoover Posted - 1 month ago

Insider Christopher Heery reports selling 7,598 shares of $ACLX for a total cost of $419,925.50 https://fintel.io/n/us/aclx/heery-christopher?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

User Image risenhoover Posted - 1 month ago

Insider Michelle Gilson reports selling 8,514 shares of $ACLX for a total cost of $470,550.90 https://fintel.io/n/us/aclx/gilson-michelle?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

User Image cctranscripts Posted - 1 month ago

Arcellx, Inc.'s See Remarks just disposed of 29,073 shares https://www.conferencecalltranscripts.org/summary/?id=12850929 $ACLX

User Image risenhoover Posted - 1 month ago

Insider Rami Elghandour reports selling 29,073 shares of $ACLX for a total cost of $1,606,803.66 https://fintel.io/n/us/aclx/elghandour-rami?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

User Image PennyFun Posted - 1 month ago

$ACLX loaded some avg 52.50✅👀✅

User Image cctranscripts Posted - 1 month ago

Securities to be offered to employees in employee benefit plans https://www.conferencecalltranscripts.org/summary/?id=12834763 $ACLX

User Image risenhoover Posted - 1 month ago

$ACLX / Arcellx files S-8 registration statement (stock option plan) https://fintel.io/doc/sec-arcellx-inc-1786205-s8-2024-january-02-19724-6668?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image FlynancialAnalyst Posted - 1 month ago

$ACLX

User Image AnchorsAweigh Posted - 1 month ago

$ACLX looks great

User Image ivanhoff Posted - 1 month ago

2024 started with a rotation into biotech and healthcare. $ACLX is a 2022 biotech IPO setting up near its all-time highs. Thinly traded. @IBDinvestors @MarketSmith #IBDpartner bit.ly/44IcxO1

User Image BobBuran Posted - 1 month ago

Tuesday This is the second of two posts showing a total of about 50 of my buy stop orders above the market for today. Already bot past ten minutes: $TNGX $ACLX $TOI $CDIO #stocks

User Image BobBuran Posted - 1 month ago

Tuesday This is the first of two posts showing a total of about 50 of my buy stop orders above the market for today. Already bot past ten minutes: $TNGX $ACLX $TOI $CDIO #stocks

User Image cctranscripts Posted - 12/28/23

Report of proposed sale of securities https://www.conferencecalltranscripts.org/summary/?id=12827511 $ACLX

Analyst Ratings
Needham Buy Jan 4, 24
Scotiabank Sector Outperform Dec 19, 23
Needham Buy Dec 12, 23
Needham Buy Dec 11, 23
HC Wainwright & Co. Buy Nov 15, 23
Needham Buy Nov 15, 23
TD Cowen Outperform Oct 30, 23
UBS Buy Oct 17, 23
Baird Outperform Aug 15, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Heery Christopher Chief Medical Office.. Chief Medical Officer Jan 02 Option 0.00 16,519 25,457 01/04/24
Gilson Michelle Chief Financial Offi.. Chief Financial Officer Jan 02 Option 0.00 15,339 24,824 01/04/24
Elghandour Rami See Remarks See Remarks Jan 02 Option 0.00 53,097 89,266 01/04/24
Heery Christopher Chief Medical Office.. Chief Medical Officer Aug 04 Sell 35.38 3,000 106,140 7,795 08/07/23
Heery Christopher Chief Medical Office.. Chief Medical Officer Aug 04 Option 15 3,000 45,000 10,795 08/07/23
Heery Christopher Chief Medical Office.. Chief Medical Officer Jul 03 Sell 31.75 3,000 95,250 7,795 07/05/23
Heery Christopher Chief Medical Office.. Chief Medical Officer Jul 03 Option 15 3,000 45,000 10,795 07/05/23
Elghandour Rami See Remarks See Remarks May 31 Sell 44.2688 2,600 115,099 36,169 06/02/23
Gilson Michelle Chief Financial Offi.. Chief Financial Officer May 23 Sell 42.29 14,704 621,832 9,485 05/25/23
Gilson Michelle Chief Financial Offi.. Chief Financial Officer May 23 Option 0 22,428 24,189 05/25/23
Carroll Jill Director Director May 11 Sell 45.58 638,417 29,099,047 2,828,394 05/15/23
SR ONE CAPITAL MANAGEMENT, LLC 10% Owner 10% Owner May 11 Sell 45.58 1,012,833 46,164,928 1,658,780 05/15/23
Heery Christopher Chief Medical Office.. Chief Medical Officer May 05 Sell 45.0017 1,200 54,002 10,492 05/08/23
Heery Christopher Chief Medical Office.. Chief Medical Officer Apr 03 Sell 30.9 3,000 92,700 15,589 04/04/23
Heery Christopher Chief Medical Office.. Chief Medical Officer Apr 03 Option 15 3,000 45,000 18,589 04/04/23
Heery Christopher Chief Medical Office.. Chief Medical Officer Feb 07 Sell 30.77 6,966 214,344 15,589 02/09/23
Heery Christopher Chief Medical Office.. Chief Medical Officer Feb 07 Option 0 22,555 22,555 02/09/23
Elghandour Rami See Remarks See Remarks Feb 07 Sell 30.77 31,442 967,470 38,769 02/09/23
Elghandour Rami See Remarks See Remarks Feb 07 Option 0 70,211 70,211 02/09/23
SANDELL SCOTT D 10% Owner 10% Owner Dec 23 Sell 31.67 390 12,351 12/27/22
SANDELL SCOTT D 10% Owner 10% Owner Dec 20 Sell 30.74 179 5,502 12/22/22
New Enterprise Associates 15,... 10% Owner 10% Owner Jun 21 Buy 16.00 312,500 5,000,000 6,745,262 06/23/22
SR ONE CAPITAL MANAGEMENT, LLC 10% Owner 10% Owner Feb 08 Buy 15 1,666,667 25,000,005 2,033,196 02/10/22
New Enterprise Associates 15,... 10% Owner 10% Owner Feb 08 Buy 15 1,583,333 23,749,995 6,432,762 02/09/22
Carroll Jill Director Director Feb 08 Buy 15 1,666,667 25,000,005 2,033,196 02/09/22
Novo Holdings A/S 10% Owner 10% Owner Feb 08 Buy 15 833,333 12,499,995 4,016,878 02/09/22